TOMASSETTI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.041
AS - Asia 3.960
EU - Europa 2.608
SA - Sud America 772
AF - Africa 102
OC - Oceania 46
Totale 12.529
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.950
RU - Federazione Russa 1.399
CN - Cina 1.126
SG - Singapore 1.069
BR - Brasile 613
HK - Hong Kong 534
VN - Vietnam 446
IT - Italia 386
KR - Corea 385
IE - Irlanda 172
FR - Francia 135
DE - Germania 111
BD - Bangladesh 104
FI - Finlandia 97
SE - Svezia 90
IN - India 84
GB - Regno Unito 59
AR - Argentina 57
ID - Indonesia 57
PL - Polonia 48
AU - Australia 45
CA - Canada 34
EC - Ecuador 30
JO - Giordania 26
MX - Messico 25
NL - Olanda 25
ZA - Sudafrica 20
EG - Egitto 19
IQ - Iraq 19
JP - Giappone 19
PE - Perù 16
NG - Nigeria 15
UA - Ucraina 14
CO - Colombia 13
ES - Italia 13
PK - Pakistan 12
PY - Paraguay 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 10
AT - Austria 10
CL - Cile 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
JM - Giamaica 8
MA - Marocco 8
BJ - Benin 7
CI - Costa d'Avorio 7
PH - Filippine 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
KE - Kenya 6
AL - Albania 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
TN - Tunisia 5
TR - Turchia 5
UY - Uruguay 5
BO - Bolivia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
PA - Panama 4
RS - Serbia 4
AZ - Azerbaigian 3
BE - Belgio 3
BG - Bulgaria 3
CR - Costa Rica 3
IL - Israele 3
LT - Lituania 3
PT - Portogallo 3
RO - Romania 3
SC - Seychelles 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
LV - Lettonia 2
MK - Macedonia 2
MM - Myanmar 2
MY - Malesia 2
SI - Slovenia 2
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
GT - Guatemala 1
HU - Ungheria 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
Totale 12.521
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.018
Singapore 807
Ashburn 733
Hong Kong 488
Hefei 426
Seoul 385
San Jose 222
Dublin 166
Ho Chi Minh City 164
Fairfield 158
Beijing 106
Hanoi 104
Moscow 98
Altamura 92
Lawrence 92
Lauterbourg 91
Los Angeles 88
Council Bluffs 73
Florence 71
Buffalo 68
Dallas 66
The Dalles 64
Houston 58
New York 57
Princeton 51
Kent 46
Medford 45
Warsaw 44
Melbourne 43
Cambridge 42
Helsinki 42
São Paulo 41
Wilmington 41
Woodbridge 40
Jakarta 39
Munich 38
Chandler 35
Milan 33
Seattle 32
Chicago 30
Lappeenranta 30
San Diego 30
Frankfurt am Main 29
Mumbai 28
Turku 25
Boston 24
Shanghai 24
Da Nang 23
Boardman 22
Bengaluru 21
Rio de Janeiro 21
Ann Arbor 19
Shenzhen 19
Haiphong 16
Tokyo 16
Abuja 14
Belo Horizonte 14
Curitiba 14
Paris 14
Porto Alegre 14
Guangzhou 13
Amsterdam 11
Rome 11
Toronto 11
Cairo 10
Denver 10
Guayaquil 10
Hải Dương 10
London 10
Salt Lake City 10
Brasília 9
Can Tho 9
Marcará 9
Tashkent 9
Atlanta 8
Biên Hòa 8
Johannesburg 8
Nuremberg 8
Santo André 8
Thái Nguyên 8
Abidjan 7
Andover 7
Baghdad 7
Barnet 7
Cotonou 7
Mexico City 7
Montes Claros 7
Norwalk 7
Poplar 7
Quito 7
San Francisco 7
Bologna 6
Catania 6
Charlotte 6
Chennai 6
Dong Ket 6
Medellín 6
Ninh Bình 6
Stockholm 6
Tampa 6
Totale 8.075
Salva come PNG Salva come JPEG
Nome #
Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes 212
Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: An international case-cohort study 209
The ThinICE protocol: the combination of cryobiopsy and ultraThin bronchoscopy for the peripheral lung nodule 188
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 180
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 174
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 173
Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study 170
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 166
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 165
Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients 164
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 164
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 160
Presentation and progression of MPO-ANCA interstitial lung disease 159
Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium 148
Images in Sarcoidosis: new section of our Journal 147
Improvement in the management of nontuberculous mycobacteria after lobar collapse therapy with Endobronchial valves (EBV) 146
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 145
Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases 143
COUNTERPOINT: Should Surgical Lung Biopsy Still Be Performed for Interstitial Lung Disease Evaluation? No 142
Assessing coronavirus disease 2019 (COVID-19) transmission to healthcare personnel: The global ACT-HCP case-control study 141
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants 139
Laboratory data and broncho-alveolar lavage on Covid-19 patients with no intensive care unit admission: Correlation with chest CT features and clinical outcomes 139
Assessment of lung cancer development in idiopathic pulmonary fibrosis patients using quantitative high-resolution computed tomography: a retrospective analysis 139
Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab 138
Antiviral combination regimens as rescue therapy in immunocompromised hosts with persistent COVID-19 137
Idiopathic pulmonary fibrosis: Prognostic impact of histologic honeycombing in transbronchial lung cryobiopsy 137
European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases 136
Cryobiopsies are diagnostic in Pleuroparenchymal and Airway-centered Fibroelastosis 136
Airway-Centered Pleuroparenchymal Fibroelastosis Associated with Non-Necrotizing Granulomas: A Rare New Entity 136
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do? 135
Predictors of Worse Prognosis in Young and Middle-Aged Adults Hospitalized with COVID-19 Pneumonia: A Multi-Center Italian Study (COVID-UNDER50) 135
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 134
Ultrasonography for the Diagnosis of Pneumothorax after Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases 134
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis 132
Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure 131
Cryobiopsy in the diagnosis of bronchiolitis: a retrospective analysis of twenty-three consecutive patients 131
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 130
Historical eye on IPF: a cohort study redefining the mortality scenario 129
Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study 129
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial 129
Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis 127
Microbiota and IPF: hidden and detected relationships 126
Incidental discovery of interstitial lung disease: Diagnostic approach, surveillance and perspectives 125
Pulmonary vein stenosis mimicking interstitial lung disease 125
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective 124
A pilot study on the use of the super dimension navigation system for optimal cryobiopsy location in interstitial lung disease diagnostics 124
Report standardization in transbronchial lung cryobiopsy 122
Nintedanib in progressive fibrosing interstitial lung diseases 121
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 120
The prognostic role of gender-age-physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 120
Invasive diagnostic techniques in idiopathic interstitial pneumonias 117
Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature 117
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 117
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease 116
Supine vs prone position in mild to moderate COVID-19 pneumonia: The impact of proning on computed tomography findings 115
How might transbronchial cryobiopsy improve diagnosis and treatment of diffuse parenchymal lung disease patients? 114
Transbronchial cryobiopsy: an effective tool in the diagnosis of lymphoproliferative disorders of the lung 114
Update of penetrance estimates in Birt-Hogg-Dubé syndrome 113
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here? 113
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype 112
A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis 112
Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: A prospective multicenter study of the European DRAGON consortium 111
From "traction bronchiectasis" to honeycombing in idiopathic pulmonary fibrosis: A spectrum of bronchiolar remodeling also in radiology? 111
Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone 110
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: results of a Delphi survey 110
Editorial: Are we ready for prime time? 109
Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Disease: Comparison between Biopsy from 1 Segment and Biopsy from 2 Segments-Diagnostic Yield and Complications 109
Transbronchial Cryobiopsy in Diffuse Lung Disease: Update for the Pathologist 107
Transbronchial Cryobiopsy in the Diagnosis of Diffuse Lung Disease 107
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe 107
Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis 106
An HIV + patient with visceral enlarged lymphnodes 106
Diffuse parenchymal lung disease 105
"Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation" related entities. A narrative review 105
The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs 104
"Gallia est omnis divisa in partes tres": Is it time to divide Pleuroparenchymal Fibroelastosis in three different forms? 103
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis 102
Oxygen in patients with fibrotic interstitial lung disease: aninternational Delphi survey 102
Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial 102
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities 101
Detection and early referral of patients with interstitial lung abnormalities: an expert survey initiative 100
Angiosarcoma in the chest: radiologic-pathologic correlation: Case report 100
Idiopathic Pulmonary Fibrosis 99
Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity 99
OSA and Prolonged Oxygen Desaturation During Sleep are Strong Predictors of Poor Outcome in IPF 98
Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey 97
Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis 96
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review 95
Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases 93
Quality of life in idiopathic pulmonary fibrosis: The impact of sleep disordered breathing 93
Rebuttal From Dr Tomassetti et al 91
New idiopathic pulmonary fibrosis guidelines: Are cryobiopsy and surgery competitive in clinical practice? 90
Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients 90
Unsupervised machine learning identifies predictive progression markers of IPF 87
Time to Trust Transbronchial Cryobiopsy in Identification of Usual Interstitial Pneumonia Pattern 87
Transbronchial cryobiopsy in diffuse parenchymal lung diseases 86
Pinocchio and Interstitial Lung Abnormalities: Is It Just Another Lie? 85
Long-term safety of pirfenidone: Results of the prospective, observational PASSPORT study 84
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis 82
Nonspecific Interstitial Pneumonia: What Is the Optimal Approach to Management? 75
Totale 12.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/2022523 6 205 13 12 7 28 35 16 4 33 65 99
2022/2023659 75 195 31 22 7 101 89 8 66 28 28 9
2023/2024372 3 38 61 29 32 26 7 72 17 59 21 7
2024/20255.066 114 303 251 713 1.526 902 143 326 189 107 170 322
2025/20265.822 635 965 880 711 531 211 620 274 305 320 311 59
Totale 12.667